e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Pathogenesis and treatment of asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improvement in quality of life with tiotropium in smokers and quitters with COPD
T. Glaab, N. Metzdorf, K. Wolf, H. Rau-Berger (Ingelheim, Germany)
Source:
Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD
Session:
Pathogenesis and treatment of asthma and COPD
Session type:
Thematic Poster Session
Number:
3612
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Glaab, N. Metzdorf, K. Wolf, H. Rau-Berger (Ingelheim, Germany). Improvement in quality of life with tiotropium in smokers and quitters with COPD. Eur Respir J 2008; 32: Suppl. 52, 3612
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Impact of quit smoking on quality of life in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 391s
Year: 2005
Quality of life after 2 months smoking cessation in smokers with and without COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 193s
Year: 2001
Smoking cessation and influence on health-related quality of life in COPD patients
Source: Annual Congress 2009 - Tobacco, bronchial tubes and the lung
Year: 2009
Health-related quality of life (HRQL) and use of formoterol in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 55s
Year: 2001
Self-efficacy and quality of life in COPD patients
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012
NVA237 once daily improves dyspnea and health-related quality of life (HRQoL) in patients with COPD: The GLOW1 trial
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011
Influence of smoking on quality of life (QoL) and dyspnoea in patients with COPD
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
Related quality of life and quit smoking COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 390s
Year: 2005
Reducing exacerbations leads to a better health-related quality of life in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 238s
Year: 2003
Indacaterol once-daily improves health-related quality of life in COPD patients: a 26-week comparison with placebo and tiotropium
Source: Annual Congress 2009 - New bronchodilators
Year: 2009
Adherence to GOLD guidelines and health-related quality of life in outpatients with COPD
Source: Annual Congress 2009 - Healthcare and treatment of COPD
Year: 2009
The impact of depression and anxiety on never-smokers COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
Source: Eur Respir J 2002; 19: 209-216
Year: 2002
Satisfaction with inhaled asthma medication and patients quality of life
Source: Eur Respir J 2004; 24: Suppl. 48, 285s
Year: 2004
The association between health-related quality of life and COPD exacerbations measured by EQ-5D-5L in the ETHOS trial
Source: Virtual Congress 2021 – Inhaled treatments for COPD: clinical trials and real-world studies
Year: 2021
Health-related quality of life and asthma control in patients treated with budesonide and formoterol in a single inhaler
Source: Eur Respir J 2001; 18: Suppl. 33, 46s
Year: 2001
Effect of roflumilast on quality of life in frequent and infrequent exacerbators
Source: Annual Congress 2013 –COPD drugs: new findings
Year: 2013
Predicting quality of life in COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 515s
Year: 2004
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept